Orkla ASA (LON:0FIN)
110.22
+0.72 (0.65%)
At close: Aug 8, 2025
Lumos Pharma Market Cap
Orkla ASA has a market cap or net worth of 7.96 billion as of August 8, 2025. Its market cap has increased by 25.54% in one year.
Market Cap
7.96B
Enterprise Value
9.64B
Revenue
5.18B
Ranking
n/a
PE Ratio
10.45
Stock Price
$110.22
Market Cap Chart
Since April 14, 1998, Orkla ASA's market cap has increased from 3.23B to 7.96B, an increase of 146.14%. That is a compound annual growth rate of 3.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 7.96B | 15.30% |
Dec 30, 2024 | 6.90B | 13.39% |
Dec 29, 2023 | 6.09B | 2.19% |
Dec 30, 2022 | 5.96B | -19.48% |
Dec 30, 2021 | 7.40B | -1.21% |
Dec 30, 2020 | 7.49B | -2.88% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 169.37B |
HSBC Holdings | 162.73B |
Shell | 155.70B |
Unilever | 112.14B |
British American Tobacco p.l.c. | 92.38B |
Rolls-Royce Holdings | 90.11B |
Rio Tinto Group | 77.80B |
BP p.l.c. | 65.50B |